Skip to main content
. Author manuscript; available in PMC: 2013 Jun 21.
Published in final edited form as: Cancer Lett. 2010 Jul 31;298(2):212–221. doi: 10.1016/j.canlet.2010.07.007

Fig. 1.

Fig. 1

Cytotoxic effect of decursin against human leukemic cells. (A) Chemical structure of decursin (MW. 328). (B) Human leukemia KBM-5, HL-60 and U937 cells and human peripheral blood lymphocyte (PBL) cells were incubated with various concentrations of decursin for 24 h. Cell viability was determined by the XTT assay. The data represent mean ± S.D. Statistically significant difference was calculated by Student's t-test. *, p < 0.05, **, p < 0.01 and **, p < 0.001 versus control. (C) Western blotting was performed using cell lysates from human leukemia KBM-5, HL-60 and U937 cells with anti-PKC antibody.